Postoperative Opioid Use and Associated Outcomes after Breast Cancer Surgery in the United States: A Systematic Review
摘要
This systematic review evaluated opioid consumption and associated outcomes among breast cancer patients in the United States (US) who underwent curative surgery.
Recent findingsA total of 11 studies involving 97,093 patients met inclusion criteria. Postoperative opioid use was common, with considerable variation in prescribing practices. Several interventions, including liposomal bupivacaine, opioid-free anesthesia, and prepectoral reconstruction, were associated with reduced opioid use, improved pain control, shorter hospital stays, and fewer opioid-related adverse events such as nausea and vomiting.
SummaryAlthough postoperative opioid use is common among patients undergoing breast cancer surgery, implementation of alternative pain management strategies and opioid-minimizing protocols can potentially reduce opioid consumption and opioid-related adverse events while improving patient outcomes.